CD4 and diabetic kidney disease: Seo (79) and his colleagues reported that Mycophenolate Mofetil can alleviate diabetic nephropathy in db/db mice, followed by decreased albuminuria, attenuated mesangial expansion, and profibrotic mRNA expressions through downregulating the infiltrated CD4+ and CD8+ T cells.